FDA tightens AI regulations to enhance patient safety while fostering healthcare innovation
As AI technology advances rapidly, the FDA faces the challenge of balancing innovation with patient safety by developing regulations that ensure AI tools remain effective throughout their lifecycle. A Special Communication published in the Journal of the American Medical Association (JAMA) discusses the U.S. Food and Drug Administration’s (FDA) approach to regulating artificial intelligence (AI) … Read more